Accelerate Diagnostics In...
1.08
-0.05 (-4.42%)
At close: Jan 14, 2025, 3:59 PM
1.08
0.00%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 1.04
Market Cap 27.05M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -2.59
PE Ratio (ttm) -0.42
Forward PE n/a
Analyst Hold
Ask 1.28
Volume 34,125
Avg. Volume (20D) 67,311
Open 1.16
Previous Close 1.13
Day's Range 1.06 - 1.16
52-Week Range 0.73 - 3.05
Beta undefined

About AXDX

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also prov...

Sector Healthcare
IPO Date Apr 7, 1994
Employees 134
Stock Exchange NASDAQ
Ticker Symbol AXDX

Analyst Forecast

According to 1 analyst ratings, the average rating for AXDX stock is "Hold." The 12-month stock price forecast is $1, which is a decrease of -7.41% from the latest price.

Buy 0.00%
Hold 100.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Accelerate Diagnostics Inc. is scheduled to release its earnings on Mar 27, 2025, during market hours.
Analysts project revenue of $3.00M, reflecting a -0.89% YoY shrinking and earnings per share of -0.5, making a -43.82% decrease YoY.